• On July 14, 2026, C3.ai, Inc. reported that a U.S. federal court dismissed in full a putative securities class action lawsuit filed against the company and certain officers in August 2025, removing all asserted causes of action.
• This legal outcome lifts a significant source of uncertainty around potential litigation exposure and compliance concerns that had been hanging over C3.ai’s operations and governance.
• With the securities lawsuit dismissed, we’ll examine how reduced legal overhang interacts with C3.ai’s AI partnerships and ongoing operating losses.

Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.

C3.ai Investment Narrative Recap

To own C3.ai, you need to believe its enterprise AI platform and hyperscaler partnerships can offset steep revenue declines and ongoing heavy losses. The full dismissal of the 2025 securities class action removes a legal overhang but does not change the core near term story, which is still dominated by shrinking revenue, negative free cash flow, and dependence on partners like Microsoft Azure, AWS, and Google Cloud for most new business.

This legal clean-up sits alongside C3.ai’s recent multi year extension with Shell for C3 AI Reliability on Microsoft Azure, which speaks directly to the key catalyst: converting existing deployments into stickier, scaled use across large industrial customers. Together, reduced litigation risk and visible renewals from major clients help support the partnership driven growth thesis, even as execution issues and profitability challenges remain front and center.

Yet, against this progress, investors still need to be aware of how C3.ai’s widening operating losses and partner concentration could...

C3.ai's narrative projects $269.8 million revenue and $32.7 million earnings by 2029. This requires 2.5% yearly revenue growth and about a $503 million earnings increase from -$470.4 million today.

Uncover how C3.ai's forecasts yield a $8.82 fair value, in line with its current price.

Exploring Other Perspectives

While the lawsuit dismissal eases one concern, the most pessimistic analysts still assume revenue of about US$252.6 million by 2029 and continued pressure from open source and in house AI solutions, so you should recognize that informed views on C3.ai’s long term prospects can differ widely and consider how these expectations might shift as new information emerges.

Explore 7 other fair value estimates on C3.ai - why the stock might be worth 33% less than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your C3.ai research is our analysis highlighting 3 important warning signs that could impact your investment decision.
• Our free C3.ai research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate C3.ai's overall financial health at a glance.

Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.